Hôpital Saint-Eloi

Montpellier 34295

0 studies enrolling now · 7 studies all time

What they study most

Chronic Spontaneous Urticaria, Diffuse Large B-Cell Lymphoma, Hepatocellular Carcinoma, Lymphocytic Leukemia, Chronic, Lymphoma, Non-Hodgkin, Mantle Cell Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin Lymphoma, Unresectable Hepatocellular Carcinoma

Studies at this site

• Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia — Completed
• Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors — Completed
• Study to Evaluate Tezepelumab in Adults With Chronic Spontaneous Urticaria — Completed
• Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) — Stopped early
• Study to Evaluate the Efficacy and Safety of Camidanlumab Tesirine (ADCT-301) in Patients With Relapsed or Refractory Hodgkin Lymphoma — Completed
• Safety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma — Stopped early
• Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer — Completed